Why was this course developed?
The South East region has a significant Life Sciences cluster, with c. 7,500 people employed and c. 1,700 new jobs projected over the next 3-5 years. There is a skills shortage at higher levels (Level 8-9) for expert scientists and technicians to perform formulation and other R&D activities. In response, companies are having to identify people within their organisations that can develop these skills, and are looking to work with WIT to put in place the training to upskill these key staff. The forecast growth in the sector in the South East is expected to make this shortage more acute and is creating an imperative to increase the numbers of people that are trained in these high-skill areas.
The Future Skills Needs of the Biopharma industry in Ireland report published in 2016 highlighted a need for advanced scientific skills at L8/L9. The National Skills Bulletin 2016 highlighted a shortage of Analytical Development Chemists, Formulation Scientists, R&D Scientists, and QC Analysts. The skills shortage in advanced formulation applies to approximately 15 companies (pharmaceutical companies in or moving to the region), who collectively require a skills pool of 40-50 formulation scientists. Allowing for promotions, retirements and people moving in and out of the region, it is estimated that there is a need to train at least ten people per annum to the level required.
What are the learning outcomes?
On successful completion of this module, a student will be able to:
•Appraise the principles of pharmaceutical/biopharmaceutical pre-formulation with respect to the overall design and development of drug delivery systems.
•Evaluate how the physicochemical properties of drug molecules and excipients influence the choice of drug dosage form and subsequent formulation and manufacturing procedures.
•Propose a formulation design and method of manufacture taking into account the physicochemical properties of drug molecules and excipients.
•Establish method development strategies involved in lyophilisation, spray drying and aerosol drug formulation.
•Produce a protocol for the stability testing of a pharmaceutical product